Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

European Journal of Vascular and Endovascular Surgery

Volumn 55, Issue 3, 2018, Pages 305-368

  Aboyans, Victor ^a   Ricco, Jean Baptiste ^a   Bartelink, Marie Louise E L ^a   Björck, Martin ^a   Brodmann, Marianne ^a   Cohnert, Tina ^a   Collet, Jean Philippe ^a   Czerny, Martin ^a   De Carlo, Marco ^a   Debus, Sebastian ^a   Espinola Klein, Christine ^a   Kahan, Thomas ^a   Kownator, Serge ^a   Mazzolai, Lucia ^a   Naylor, A Ross ^a   Roffi, Marco ^a   Röther, Joachim ^a   Sprynger, Muriel ^a   Tendera, Michal ^a   Tepe, Gunnar ^a   Venermo, Maarit ^a   Vlachopoulos, Charalambos ^a   Desormais, Ileana ^a   Widimsky, Petr ^a   Kolh, Philippe ^a   Agewall, Stefan ^a   Bueno, Héctor ^a   Coca, Antonio ^a   De Borst, Gert J ^a   Delgado, Victoria ^a   Dick, Florian ^a   Erol, Cetin ^a   Ferrini, Marc ^a   Kakkos, Stavros ^a   Katus, Hugo A ^a   Knuuti, Juhani ^a   Sanddal Lindholt, Jes ^a   Mattle, Heinrich ^a   Pieniazek, Piotr ^a   Piepoli, Massimo Francesco ^a   Scheinert, Dierk ^a   Sievert, Horst ^a   Simpson, Iain ^a   Sulzenko, Jakub ^a   Tamargo, Juan ^a   Tokgozoglu, Lale ^a   Torbicki, Adam ^a   Tsakountakis, Nikolaos ^a   Tuñón, José ^a   de Ceniga, Melina Vega ^a   Windecker, Stephan ^a   Zamorano, Jose Luis ^a   de Borst, G J ^a   Chakfe, N ^a   Debus, S ^a   Hinchliffe, R ^a   Koncar, I ^a   Vega de Ceniga, M ^a   Vermassen, F ^a   Verzini, F ^a   more..

^a NONE

Author keywords

Carotid artery disease; Guidelines; Lower extremity artery disease; Mesenteric artery disease; Multisite artery disease; Peripheral arterial diseases; Renal artery disease; Upper extremity artery disease; Vertebral artery disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CLOPIDOGREL;

AMPUTATION; ANKLE BRACHIAL INDEX; ANTICOAGULATION; ARTERY DISEASE; ARTERY OCCLUSION; ARTICLE; ATRIAL FIBRILLATION; CAROTID ARTERY DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC APPROACH ROUTE; DIGITAL SUBTRACTION ANGIOGRAPHY; DUAL ANTIPLATELET THERAPY; ECHOGRAPHY; ENDOVASCULAR SURGERY; EUROPE; GENE THERAPY; HEART FAILURE; INTERMITTENT CLAUDICATION; KIDNEY ARTERY; KINESIOTHERAPY; LABORATORY TEST; LIMB ISCHEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL HISTORY; MEDICAL SOCIETY; MESENTERIC ISCHEMIA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SMOKING CESSATION; STEM CELL TRANSPLANTATION; VALVULAR HEART DISEASE; VASCULAR ACCESS; VERTEBRAL ARTERY; CARDIOVASCULAR SYSTEM EXAMINATION; DISEASE MANAGEMENT; HUMAN; STANDARDS; VASCULAR SURGERY;

DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE MANAGEMENT; EUROPE; HUMANS; PERIPHERAL ARTERIAL DISEASE; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; VASCULAR SURGICAL PROCEDURES;

EID: 85028421834     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2017.07.018     Document Type: Article

References (421)

1. Tendera, M., Aboyans, V., Bartelink, M.L., Baumgartner, I., Clement, D., Collet, J.P., et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32 (2011), 2851–2906.
2. Fowkes, F.G., Rudan, D., Rudan, I., Aboyans, V., Denenberg, J.O., McDermott, M.M., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382 (2013), 1329–1340.
3. Belcaro, G., Nicolaides, A.N., Ramaswami, G., Cesarone, M.R., De Sanctis, M., Incandela, L., et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study). Atherosclerosis 156 (2001), 379–387.
4. Giannopoulos, A., Kakkos, S., Abbott, A., Naylor, A.R., Richards, T., Mikhailidis, D.P., et al. Long-term mortality in patients with asymptomatic carotid stenosis: implications for statin therapy. Eur J Vasc Endovasc Surg 50 (2015), 573–582.
5. Criqui, M.H., Aboyans, V., Epidemiology of peripheral artery disease. Circ Res 116 (2015), 1509–1526.
6. Fowkes, F.G., Murray, G.D., Butcher, I., Heald, C.L., Lee, R.J., Chambless, L.E., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300 (2008), 197–208.
7. Weitz, J.I., Byrne, J., Clagett, G.P., Farkouh, M.E., Porter, J.M., Sackett, D.L., et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 94 (1996), 3026–3049.
8. Valentine, R.J., Guerra, R., Stephan, P., Scoggins, E., Clagett, G.P., Cohen, J., Family history is a major determinant of subclinical peripheral arterial disease in young adults. J Vasc Surg 39 (2004), 351–356.
9. Wassel, C.L., Loomba, R., Ix, J.H., Allison, M.A., Denenberg, J.O., Criqui, M.H., Family history of peripheral artery disease is associated with prevalence and severity of peripheral artery disease: the San Diego population study. J Am Coll Cardiol 58 (2011), 1386–1392.
10. Khaleghi, M., Isseh, I.N., Bailey, K.R., Kullo, I.J., Family history as a risk factor for peripheral arterial disease. Am J Cardiol 114 (2014), 928–932.
11. Corra, U., Piepoli, M.F., Carre, F., Heuschmann, P., Hoffmann, U., Verschuren, M., et al. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur Heart J 31 (2010), 1967–1974.
12. Craig, C.L., Marshall, A.L., Sjostrom, M., Bauman, A.E., Booth, M.L., Ainsworth, B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35 (2003), 1381–1395.
13. Washburn, R.A., Smith, K.W., Jette, A.M., Janney, C.A., The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46 (1993), 153–162.
14. Pickett, C.A., Jackson, J.L., Hemann, B.A., Atwood, J.E., Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis. Lancet 371 (2008), 1587–1594.
15. Clark, C.E., Taylor, R.S., Shore, A.C., Ukoumunne, O.C., Campbell, J.L., Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet 379 (2012), 905–914.
16. Cournot, M., Taraszkiewicz, D., Cambou, J.P., Galinier, M., Boccalon, H., Hanaire-Broutin, H., et al. Additional prognostic value of physical examination, exercise testing, and arterial ultrasonography for coronary risk assessment in primary prevention. Am Heart J 158 (2009), 845–851.
17. Vlachopoulos, C., Xaplanteris, P., Aboyans, V., Brodmann, M., Cifkova, R., Cosentino, F., et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis 241 (2015), 507–532.
18. Criqui, M.H., McClelland, R.L., McDermott, M.M., Allison, M.A., Blumenthal, R.S., Aboyans, V., et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 56 (2010), 1506–1512.
19. Wu, M.Y., Hsiang, H.F., Wong, C.S., Yao, M.S., Li, Y.W., Hsiang, C.Y., et al. The effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials. Int Urol Nephrol 45 (2013), 1309–1318.
20. O'Sullivan, S., Healy, D.A., Moloney, M.C., Grace, P.A., Walsh, S.R., The role of N-acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis. Angiology 64 (2013), 576–582.
21. Merten, G.J., Burgess, W.P., Gray, L.V., Holleman, J.H., Roush, T.S., Kowalchuk, G.J., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004), 2328–2334.
22. Akyuz, S., Yaylak, B., Altay, S., Kasikcioglu, H., Cam, N., The role of statins in preventing contrast-induced acute kidney injury: a narrative review. Angiology 66 (2015), 701–707.
23. Ramalho, J., Semelka, R.C., Ramalho, M., Nunes, R.H., AlObaidy, M., Castillo, M., Gadolinium-based contrast agent accumulation and toxicity: an update. AJNR Am J Neuroradiol 37 (2016), 1192–1198.
24. Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 28 (2007), 2375–2414.
25. Piepoli, M.F., Hoes, A.W., Agewall, S., Albus, C., Brotons, C., Catapano, A.L., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37 (2016), 2315–2381.
26. Ryden, L., Grant, P.J., Anker, S.D., Berne, C., Cosentino, F., Danchin, N., et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34 (2013), 3035–3087.
27. Bullen, C., Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther 6 (2008), 883–895.
28. Lim, S.S., Vos, T., Flaxman, A.D., Danaei, G., Shibuya, K., Adair-Rohani, H., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2224–2260.
29. Morris, P.B., Ference, B.A., Jahangir, E., Feldman, D.N., Ryan, J.J., Bahrami, H., et al. Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: clinical perspectives from the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. J Am Coll Cardiol 66 (2015), 1378–1391.
30. Aung, P.P., Maxwell, H.G., Jepson, R.G., Price, J.F., Leng, G.C., Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev, 4, 2007, CD000123.
31. Antoniou, G.A., Fisher, R.K., Georgiadis, G.S., Antoniou, S.A., Torella, F., Statin therapy in lower limb peripheral arterial disease: systematic review and meta-analysis. Vascul Pharmacol 63 (2014), 79–87.
32. Heart Protection Study Collaborative Group, Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 45 (2007), 645–654.
33. Kumbhani, D.J., Steg, P.G., Cannon, C.P., Eagle, K.A., Smith, S.C. Jr., Goto, S., et al. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J 35 (2014), 2864–2872.
34. Westin, G.G., Armstrong, E.J., Bang, H., Yeo, K.K., Anderson, D., Dawson, D.L., et al. Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia. J Am Coll Cardiol 63 (2014), 682–690.
35. Murphy, S.A., Cannon, C.P., Blazing, M.A., Giugliano, R.P., White, J.A., Lokhnygina, Y., et al. Reduction in total cardiovascular events with ezetimibe/simvastatin post-acute coronary syndrome: the IMPROVE-IT Trial. J Am Coll Cardiol 67 (2016), 353–361.
36. Meade, T., Zuhrie, R., Cook, C., Cooper, J., Bezafibrate in men with lower extremity arterial disease: randomised controlled trial. BMJ, 325, 2002, 1139.
37. Amarenco, P., Labreuche, J., Lavallee, P., Touboul, P.J., Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35 (2004), 2902–2909.
38. Huang, Y., Li, W., Dong, L., Li, R., Wu, Y., Effect of statin therapy on the progression of common carotid artery intima-media thickness: an updated systematic review and meta-analysis of randomized controlled trials. J Atheroscler Thromb 20 (2013), 108–121.
39. Sabatine, M.S., Giugliano, R.P., Keech, A.C., Honarpour, N., Wiviott, S.D., Murphy, S.A., et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 376 (2017), 1713–1722.
40. Staessen, J.A., Thijs, L., Gasowski, J., Cells, H., Fagard, R.H., Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial. Am J Cardiol 82 (1998), 20R–22R.
41. Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Bohm, M., et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31 (2013), 1281–12357.
42. Bavry, A.A., Anderson, R.D., Gong, Y., Denardo, S.J., Cooper-Dehoff, R.M., Handberg, E.M., et al. Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy. Hypertension 55 (2010), 48–53.
43. Wright, J.T. Jr., Williamson, J.D., Whelton, P.K., Snyder, J.K., Sink, K.M., Rocco, M.V., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373 (2015), 2103–2116.
44. Cushman, W.C., Whelton, P.K., Fine, L.J., Wright, J.T. Jr., Reboussin, D.M., Johnson, K.C., et al. SPRINT trial results: latest news in hypertension management. Hypertension 67 (2016), 263–265.
45. World Health Organization, Guideline: sodium intake for adults and children. 2012, World Health Organization, Geneva [reprinted 2014].
46. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., Dagenais, G., Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000), 145–153.
47. Yusuf, S., Teo, K.K., Pogue, J., Dyal, L., Copland, I., Schumacher, H., et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358 (2008), 1547–1559.
48. Armstrong, E.J., Chen, D.C., Singh, G.D., Amsterdam, E.A., Laird, J.R., Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia. Vasc Med 20 (2015), 237–244.
49. Paravastu, S.C., Mendonca, D.A., Da Silva, A., Beta blockers for peripheral arterial disease. Cochrane Database Syst Rev, 9, 2013, CD005508.
50. Aronow, W.S., Ahn, C., Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. Am J Cardiol 87 (2001), 1284–1286.
51. CAPRIE Steering Committee, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996), 1329–1339.
52. Law, M.R., Morris, J.K., Wald, N.J., Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ, 338, 2009, b1665.
53. Ostergren, J., Sleight, P., Dagenais, G., Danisa, K., Bosch, J., Qilong, Y., et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 25 (2004), 17–24.
54. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002), 71–86.
55. Sacco, R.L., Diener, H.C., Yusuf, S., Cotton, D., Ounpuu, S., Lawton, W.A., et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 359 (2008), 1238–1251.
56. Bhatt, D.L., Flather, M.D., Hacke, W., Berger, P.B., Black, H.R., Boden, W.E., et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 49 (2007), 1982–1988.
57. Markus, H.S., Droste, D.W., Kaps, M., Larrue, V., Lees, K.R., Siebler, M., et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 111 (2005), 2233–2240.
58. Wang, Y., Wang, Y., Zhao, X., Liu, L., Wang, D., Wang, C., et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 369 (2013), 11–19.
59. Dalainas, I., Nano, G., Bianchi, P., Stegher, S., Malacrida, G., Tealdi, D.G., Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting. Cardiovasc Intervent Radiol 29 (2006), 519–521.
60. McKevitt, F.M., Randall, M.S., Cleveland, T.J., Gaines, P.A., Tan, K.T., Venables, G.S., The benefits of combined anti-platelet treatment in carotid artery stenting. Eur J Vasc Endovasc Surg 29 (2005), 522–527.
61. Gensicke, H., van der Worp, H.B., Nederkoorn, P.J., Macdonald, S., Gaines, P.A., van der Lugt, A., et al. Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk. J Am Coll Cardiol 65 (2015), 521–529.
62. Udell, J.A., Bonaca, M.P., Collet, J.P., Lincoff, A.M., Kereiakes, D.J., Costa, F., et al. Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials. Eur Heart J 37 (2016), 390–399.
63. Schmit, K., Dolor, R.J., Jones, W.S., Vemulapalli, S., Hasselblad, V., Subherwal, S., et al. Comparative effectiveness review of antiplatelet agents in peripheral artery disease. J Am Heart Assoc, 3, 2014, e001330.
64. Belch, J.J., Dormandy, J., Biasi, G.M., Cairols, M., Diehm, C., Eikelboom, B., et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 52 (2010), 825–833.
65. Cacoub, P.P., Bhatt, D.L., Steg, P.G., Topol, E.J., Creager, M.A., Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J 30 (2009), 192–201.
66. Fowkes, F.G., Price, J.F., Stewart, M.C., Butcher, I., Leng, G.C., Pell, A.C., et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA 303 (2010), 841–848.
67. Belch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ, 337, 2008, a1840.
68. Berger, J.S., Krantz, M.J., Kittelson, J.M., Hiatt, W.R., Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA 301 (2009), 1909–1919.
69. Hiatt, W.R., Fowkes, F.G., Heizer, G., Berger, J.S., Baumgartner, I., Held, P., et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med 376 (2017), 32–40.
70. Bonaca, M.P., Scirica, B.M., Creager, M.A., Olin, J., Bounameaux, H., Dellborg, M., et al. Vorapaxar in patients with peripheral artery disease: results from TRA2°P-TIMI 50. Circulation 127 (2013), 1522–1529.
71. Bonaca, M.P., Gutierrez, J.A., Creager, M.A., Scirica, B.M., Olin, J., Murphy, S.A., et al. Acute limb ischemia and outcomes with vorapaxar in patients with peripheral artery disease: results from the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50). Circulation 133 (2016), 997–1005.
72. Bedenis, R., Lethaby, A., Maxwell, H., Acosta, S., Prins, M.H., Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev, 2, 2015, CD000535.
73. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 355 (2000), 346–351.
74. Johnson, W.C., Williford, W.O., Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. J Vasc Surg 35 (2002), 413–421.
75. Monaco, M., Di Tommaso, L., Pinna, G.B., Lillo, S., Schiavone, V., Stassano, P., Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients. J Vasc Surg 56 (2012), 96–105.
76. Dake, M.D., Ansel, G.M., Jaff, M.R., Ohki, T., Saxon, R.R., Smouse, H.B., et al. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation 133 (2016), 1472–1483.
77. Laird, J.R., Schneider, P.A., Tepe, G., Brodmann, M., Zeller, T., Metzger, C., et al. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol 66 (2015), 2329–2338.
78. Dagher, N.N., Modrall, J.G., Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins. Semin Vasc Surg 20 (2007), 10–14.
79. Franzone, A., Piccolo, R., Gargiulo, G., Ariotti, S., Marino, M., Santucci, A., et al. Prolonged vs short duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with or without peripheral arterial disease: a subgroup analysis of the PRODIGY randomized clinical trial. JAMA Cardiol 1 (2016), 795–803.
80. Bonaca, M.P., Bhatt, D.L., Cohen, M., Steg, P.G., Storey, R.F., Jensen, E.C., et al. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med 372 (2015), 1791–1800.
81. Bonaca, M.P., Bhatt, D.L., Storey, R.F., Steg, P.G., Cohen, M., Kuder, J., et al. Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease. J Am Coll Cardiol 67 (2016), 2719–2728.
82. 2017 Guidelines for DAPT (citation pending).
83. Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37 (2016), 2893–2962.
84. Winkel, T.A., Hoeks, S.E., Schouten, O., Zeymer, U., Limbourg, T., Baumgartner, I., et al. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Eur J Vasc Endovasc Surg 40 (2010), 9–16.
85. Jones, W.S., Hellkamp, A.S., Halperin, J., Piccini, J.P., Breithardt, G., Singer, D.E., et al. Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF. Eur Heart J 35 (2014), 242–249.
86. Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H.C., Hacke, W., et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17 (2015), 1467–1507.
87. Baigent, C., Blackwell, L., Collins, R., Emberson, J., Godwin, J., Peto, R., et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373 (2009), 1849–1860.
88. Donaldson, D.R., Kester, R.C., Rajah, S.M., Hall, T.J., Sreeharan, N., Crow, M.J., The influence of platelet inhibition on the patency of femoro-popliteal Dacron bypass grafts. Vasc Endovasc Surg 19 (1985), 224–230.
89. McCollum, C., Alexander, C., Kenchington, G., Franks, P.J., Greenhalgh, R., Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. J Vasc Surg 13 (1991), 150–161.
90. Hart, R.G., Pearce, L.A., Aguilar, M.I., Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146 (2007), 857–867.
91. Lamberts, M., Lip, G.Y., Ruwald, M.H., Hansen, M.L., Ozcan, C., Kristensen, S.L., et al. Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study. J Am Coll Cardiol 63 (2014), 2689–2698.
92. Sacco, R.L., Kasner, S.E., Broderick, J.P., Caplan, L.R., Connors, J.J., Culebras, A., et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44 (2013), 2064–2089.
93. Donnan, G.A., Davis, S.M., Chambers, B.R., Gates, P.C., Surgery for prevention of stroke. Lancet 351 (1998), 1372–1373.
94. Sprynger M, RF, Moonen M, Aboyans V, Edvardsen T, Alcantara M, et al. EACVI recommendations on echovascular imaging assessment of arterial diseases: Partim I, 2017 [in preparation].
95. Esposito-Bauer, L., Saam, T., Ghodrati, I., Pelisek, J., Heider, P., Bauer, M., et al. MRI plaque imaging detects carotid plaques with a high risk for future cerebrovascular events in asymptomatic patients. PLoS One, 8, 2013, e67927.
96. Gupta, A., Kesavabhotla, K., Baradaran, H., Kamel, H., Pandya, A., Giambrone, A.E., et al. Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis. Stroke 46 (2015), 91–97.
97. Naylor, A.R., Schroeder, T.V., Sillesen, H., Clinical and imaging features associated with an increased risk of late stroke in patients with asymptomatic carotid disease. Eur J Vasc Endovasc Surg 48 (2014), 633–640.
98. Sloan, M.A., Alexandrov, A.V., Tegeler, C.H., Spencer, M.P., Caplan, L.R., Feldmann, E., et al. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 62 (2004), 1468–1481.
99. Wardlaw, J.M., Chappell, F.M., Stevenson, M., De Nigris, E., Thomas, S., Gillard, J., et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess, 10, 2006 iii–iv, ix–x, 1–182.
100. Blackshear, J.L., Cutlip, D.E., Roubin, G.S., Hill, M.D., Leimgruber, P.P., Begg, R.J., et al. Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation 123 (2011), 2571–2578.
101. Giannakopoulos, T.G., Moulakakis, K., Sfyroeras, G.S., Avgerinos, E.D., Antonopoulos, C.N., Kakisis, J.D., et al. Association between plaque echogenicity and embolic material captured in filter during protected carotid angioplasty and stenting. Eur J Vasc Endovasc Surg, 2012, 43627–43631.
102. Akkaya, E., Vuruskan, E., Gul, Z.B., Yildirim, A., Pusuroglu, H., Surgit, O., et al. Cerebral microemboli and neurocognitive change after carotid artery stenting with different embolic protection devices. Int J Cardiol 176 (2014), 478–483.
103. Bijuklic, K., Wandler, A., Hazizi, F., Schofer, J., The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial. J Am Coll Cardiol 59 (2012), 1383–1389.
104. Cano, M.N., Kambara, A.M., de Cano, S.J., Pezzi Portela, L.A., Paes, A.T., Costa, J.R. Jr., et al. Randomized comparison of distal and proximal cerebral protection during carotid artery stenting. JACC Cardiovasc Interv 6 (2013), 1203–1209.
105. Montorsi, P., Caputi, L., Galli, S., Ciceri, E., Ballerini, G., Agrifoglio, M., et al. Microembolization during carotid artery stenting in patients with high-risk, lipid-rich plaque. A randomized trial of proximal versus distal cerebral protection. J Am Coll Cardiol 58 (2011), 1656–1663.
106. Stabile, E., Esposito, G., Operator's experience is the most efficient embolic protection device for carotid artery stenting. Circ Cardiovasc Interv 6 (2013), 496–497.
107. Garg, N., Karagiorgos, N., Pisimisis, G.T., Sohal, D.P., Longo, G.M., Johanning, J.M., et al. Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: a systematic review of the current literature. J Endovasc Ther 16 (2009), 412–427.
108. Touze, E., Trinquart, L., Chatellier, G., Mas, J.L., Systematic review of the perioperative risks of stroke or death after carotid angioplasty and stenting. Stroke 40 (2009), e683–e693.
109. Zahn, R., Ischinger, T., Hochadel, M., Zeymer, U., Schmalz, W., Treese, N., et al. Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry. Eur Heart J 28 (2007), 370–375.
110. Rosenfield, K., Matsumura, J.S., Chaturvedi, S., Riles, T., Ansel, G.M., Metzger, D.C., et al. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med 374 (2016), 1011–1020.
111. Jansen, O., Fiehler, J., Hartmann, M., Bruckmann, H., Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial. Stroke 40 (2009), 841–846.
112. Gray, W.A., Rosenfield, K.A., Jaff, M.R., Chaturvedi, S., Peng, L., Verta, P., Influence of site and operator characteristics on carotid artery stent outcomes: analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) clinical study. JACC Cardiovasc Interv 4 (2011), 235–246.
113. Nallamothu, B.K., Gurm, H.S., Ting, H.H., Goodney, P.P., Rogers, M.A., Curtis, J.P., et al. Operator experience and carotid stenting outcomes in Medicare beneficiaries. JAMA 306 (2011), 1338–1343.
114. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 273 (1995), 1421–1428.
115. Halliday, A., Harrison, M., Hayter, E., Kong, X., Mansfield, A., Marro, J., et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 376 (2010), 1074–1084.
116. Halliday, A., Mansfield, A., Marro, J., Peto, C., Peto, R., Potter, J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363 (2004), 1491–1502.
117. Rothwell, P.M., Eliasziw, M., Gutnikov, S.A., Warlow, C.P., Barnett, H.J., Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 35 (2004), 2855–2861.
118. Hadar, N., Raman, G., Moorthy, D., O'Donnell, T.F., Thaler, D.E., Feldmann, E., et al. Asymptomatic carotid artery stenosis treated with medical therapy alone: temporal trends and implications for risk assessment and the design of future studies. Cerebrovasc Dis 38 (2014), 163–173.
119. Naylor, A.R., Gaines, P.A., Rothwell, P.M., Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals?. Eur J Vasc Endovasc Surg 37 (2009), 625–632.
120. Baker, W.H., Howard, V.J., Howard, G., Toole, J.F., Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS). ACAS Investigators. Stroke 31 (2000), 2330–2334.
121. Nicolaides, A.N., Kakkos, S.K., Griffin, M., Sabetai, M., Dhanjil, S., Tegos, T., et al. Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur J Vasc Endovasc Surg 30 (2005), 275–284.
122. Kakkos, S.K., Sabetai, M., Tegos, T., Stevens, J., Thomas, D., Griffin, M., et al. Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. J Vasc Surg 49 (2009), 902–909.
123. Kakkos, S.K., Nicolaides, A.N., Charalambous, I., Thomas, D., Giannopoulos, A., Naylor, A.R., et al. Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. J Vasc Surg 59 (2014), 956–967.
124. Markus, H.S., King, A., Shipley, M., Topakian, R., Cullinane, M., Reihill, S., et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol 9 (2010), 663–671.
125. King, A., Serena, J., Bornstein, N.M., Markus, H.S., Does impaired cerebrovascular reactivity predict stroke risk in asymptomatic carotid stenosis? A prospective substudy of the asymptomatic carotid emboli study. Stroke 42 (2011), 1550–1555.
126. Nicolaides, A.N., Kakkos, S.K., Kyriacou, E., Griffin, M., Sabetai, M., Thomas, D.J., et al. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J Vasc Surg 52 (2010), 1486–1496.
127. Kakkos, S.K., Griffin, M.B., Nicolaides, A.N., Kyriacou, E., Sabetai, M.M., Tegos, T., et al. The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke. J Vasc Surg 57 (2013), 609–618.
128. Gupta, A., Baradaran, H., Schweitzer, A.D., Kamel, H., Pandya, A., Delgado, D., et al. Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke 44 (2013), 3071–3077.
129. Hawkins, B.M., Kennedy, K.F., Aronow, H.D., Nguyen, L.L., White, C.J., Rosenfield, K., et al. Hospital variation in carotid stenting outcomes. JACC Cardiovasc Interv 6 (2015), 858–863.
130. Kallmayer, M.A., Tsantilas, P., Knappich, C., Haller, B., Storck, M., Stadlbauer, T., et al. Patient characteristics and outcomes of carotid endarterectomy and carotid artery stenting: analysis of the German mandatory national quality assurance registry – 2003 to 2014. J Cardiovasc Surg (Torino) 56 (2015), 827–836.
131. Werner, N., Zeymer, U., Hochadel, M., Hauptmann, K.E., Jung, J., Janicke, I., et al. Fifteen-year experience with carotid artery stenting (from the carotid artery stenting-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte). Am J Cardiol 115 (2015), 360–366.
132. Paraskevas, K.I., Kalmykov, E.L., Naylor, A.R., Stroke/death rates following carotid artery stenting and carotid endarterectomy in contemporary administrative dataset registries: a systematic review. Eur J Vasc Endovasc Surg 51 (2016), 3–12.
133. Choi, J.C., Johnston, S.C., Kim, A.S., Early outcomes after carotid artery stenting compared with endarterectomy for asymptomatic carotid stenosis. Stroke 46 (2015), 120–125.
134. Dua, A., Romanelli, M., Upchurch, G.R. Jr., Pan, J., Hood, D., Hodgson, K.J., et al. Predictors of poor outcome after carotid intervention. J Vasc Surg 64 (2016), 663–670.
135. Yadav, J.S., Wholey, M.H., Kuntz, R.E., Fayad, P., Katzen, B.T., Mishkel, G.J., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 (2004), 1493–1501.
136. Gurm, H.S., Yadav, J.S., Fayad, P., Katzen, B.T., Mishkel, G.J., Bajwa, T.K., et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med 358 (2008), 1572–1579.
137. Silver, F.L., Mackey, A., Clark, W.M., Brooks, W., Timaran, C.H., Chiu, D., et al. Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke 42 (2011), 675–680.
138. Rothwell, P.M., Eliasziw, M., Gutnikov, S.A., Fox, A.J., Taylor, D.W., Mayberg, M.R., et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361 (2003), 107–116.
139. Naylor, A.R., Sillesen, H., Schroeder, T.V., Clinical and imaging features associated with an increased risk of early and late stroke in patients with symptomatic carotid disease. Eur J Vasc Endovasc Surg 49 (2015), 513–523.
140. Stromberg, S., Gelin, J., Osterberg, T., Bergstrom, G.M., Karlstrom, L., Osterberg, K., Very urgent carotid endarterectomy confers increased procedural risk. Stroke 43 (2012), 1331–1335.
141. Loftus, I.M., Paraskevas, K.I., Johal, A., Waton, S., Heikkila, K., Naylor, A.R., et al. Delays to surgery and procedural risks following carotid endarterectomy in the UK National Vascular Registry. Eur J Vasc Endovasc Surg 52 (2016), 438–443.
142. Tsantilas, P., Kuehnl, A., Konig, T., Breitkreuz, T., Kallmayer, M., Knappich, C., et al. Short time interval between neurologic event and carotid surgery is not associated with an increased procedural risk. Stroke 47 (2016), 2783–2790.
143. Bush, C.K., Kurimella, D., Cross, L.J., Conner, K.R., Martin-Schild, S., He, J., et al. Endovascular treatment with stent-retriever devices for acute ischemic stroke: a meta-analysis of randomized controlled trials. PLoS One, 11, 2016, e0147287.
144. Berkhemer, O.A., Fransen, P.S., Beumer, D., van den Berg, L.A., Lingsma, H.F., Yoo, A.J., et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372 (2015), 11–20.
145. Brott, T.G., Hobson, R.W. 2nd, Howard, G., Roubin, G.S., Clark, W.M., Brooks, W., et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 363 (2010), 11–23.
146. Hill, M.D., Brooks, W., Mackey, A., Clark, W.M., Meschia, J.F., Morrish, W.F., et al. Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Circulation 126 (2012), 3054–3061.
147. Economopoulos, K.P., Sergentanis, T.N., Tsivgoulis, G., Mariolis, A.D., Stefanadis, C., Carotid artery stenting versus carotid endarterectomy: a comprehensive meta-analysis of short-term and long-term outcomes. Stroke 42 (2011), 687–692.
148. Bonati, L.H., Lyrer, P., Ederle, J., Featherstone, R., Brown, M.M., Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev, 9, 2012, CD000515.
149. Rantner, B., Goebel, G., Bonati, L.H., Ringleb, P.A., Mas, J.L., Fraedrich, G., The risk of carotid artery stenting compared with carotid endarterectomy is greatest in patients treated within 7 days of symptoms. J Vasc Surg 57 (2013), 619–626.
150. Meschia, J.F., Hopkins, L.N., Altafullah, I., Wechsler, L.R., Stotts, G., Gonzales, N.R., et al. Time from symptoms to carotid endarterectomy or stenting and perioperative risk. Stroke 46 (2015), 3540–3542.
151. Howard, G., Roubin, G.S., Jansen, O., Hendrikse, J., Halliday, A., Fraedrich, G., et al. Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials. Lancet 387 (2016), 1305–1311.
152. Bonati, L.H., Dobson, J., Featherstone, R.L., Ederle, J., van der Worp, H.B., de Borst, G.J., et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet 385 (2015), 529–538.
153. Brott, T.G., Howard, G., Roubin, G.S., Meschia, J.F., Mackey, A., Brooks, W., et al. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med 374 (2016), 1021–1031.
154. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351 (1998), 1379–1387.
155. Barnett, H.J., Taylor, D.W., Eliasziw, M., Fox, A.J., Ferguson, G.G., Haynes, R.B., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 339 (1998), 1415–1425.
156. Borhani Haghighi, A., Edgell, R.C., Cruz-Flores, S., Zaidat, O.O., Vertebral artery origin stenosis and its treatment. J Stroke Cerebrovasc Dis 20 (2011), 369–376.
157. Khan, S., Cloud, G.C., Kerry, S., Markus, H.S., Imaging of vertebral artery stenosis: a systematic review. J Neurol Neurosurg Psychiatry 78 (2007), 1218–1225.
158. Kumar Dundamadappa, S., Cauley, K., Vertebral artery ostial stenosis: prevalence by digital subtraction angiography, MR angiography, and CT angiography. J Neuroimaging 23 (2013), 360–367.
159. Berguer, R., Flynn, L.M., Kline, R.A., Caplan, L., Surgical reconstruction of the extracranial vertebral artery: management and outcome. J Vasc Surg 31 (2000), 9–18.
160. Kieffer, E., Praquin, B., Chiche, L., Koskas, F., Bahnini, A., Distal vertebral artery reconstruction: long-term outcome. J Vasc Surg 36 (2002), 549–554.
161. Stayman, A.N., Nogueira, R.G., Gupta, R., A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis. Stroke 42 (2011), 2212–2216.
162. Compter, A., van der Worp, H.B., Schonewille, W.J., Vos, J.A., Boiten, J., Nederkoorn, P.J., et al. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. Lancet Neurol 14 (2015), 606–614.
163. Aboyans, V., Criqui, M.H., McDermott, M.M., Allison, M.A., Denenberg, J.O., Shadman, R., et al. The vital prognosis of subclavian stenosis. J Am Coll Cardiol 49 (2007), 1540–1545.
164. Klitfod, L., Jensen, L.P., Treatment of chronic upper limb ischaemia is safe and results are good. Dan Med J, 61, 2014, A4859.
165. Daniel, V.T., Madenci, A.L., Nguyen, L.L., Eslami, M.H., Kalish, J.A., Farber, A., et al. Contemporary comparison of supra-aortic trunk surgical reconstructions for occlusive disease. J Vasc Surg 59 (2014), 1577–1582.
166. Duran, M., Grotemeyer, D., Danch, M.A., Grabitz, K., Schelzig, H., Sagban, T.A., Subclavian carotid transposition: immediate and long-term outcomes of 126 surgical reconstructions. Ann Vasc Surg 29 (2015), 397–403.
167. Burihan, E., Soma, F., Iared, W., Angioplasty versus stenting for subclavian artery stenosis. Cochrane Database Syst Rev, 10, 2011, CD008461.
168. Chatterjee, S., Nerella, N., Chakravarty, S., Shani, J., Angioplasty alone versus angioplasty and stenting for subclavian artery stenosis—a systematic review and meta-analysis. Am J Ther 20 (2013), 520–523.
169. Huttl, K., Nemes, B., Simonffy, A., Entz, L., Berczi, V., Angioplasty of the innominate artery in 89 patients: experience over 19 years. Cardiovasc Intervent Radiol 25 (2002), 109–114.
170. van de Weijer, M.A., Vonken, E.J., de Vries, J.P., Moll, F.L., Vos, J.A., de Borst, G.J., Technical and clinical success and long-term durability of endovascular treatment for atherosclerotic aortic arch branch origin obstruction: evaluation of 144 procedures. Eur J Vasc Endovasc Surg 50 (2015), 13–20.
171. Modarai, B., Ali, T., Dourado, R., Reidy, J.F., Taylor, P.R., Burnand, K.G., Comparison of extra-anatomic bypass grafting with angioplasty for atherosclerotic disease of the supra-aortic trunks. Br J Surg 91 (2004), 1453–1457.
172. Owens, L.V., Tinsley, E.A. Jr., Criado, E., Burnham, S.J., Keagy, B.A., Extrathoracic reconstruction of arterial occlusive disease involving the supraaortic trunks. J Vasc Surg 22 (1995), 217–221.
173. Song, L., Zhang, J., Li, J., Gu, Y., Yu, H., Chen, B., et al. Endovascular stenting vs. extrathoracic surgical bypass for symptomatic subclavian steal syndrome. J Endovasc Ther 19 (2012), 44–51.
174. Lee, A.D., Agarwal, S., Sadhu, D., A 7-year experience with thoracoscopic sympathectomy for critical upper limb ischemia. World J Surg 30 (2006), 1644–1647.
175. Björck, M., Koelemay, M., Acosta, S., Bastos Goncalves, F., Kölbel, T., Kolkman, J.J., et al. Management of the diseases of mesenteric arteries and veins: clinical practice guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 53 (2017), 460–510.
176. Acosta, S., Nilsson, T.K., Bjorck, M., D-dimer testing in patients with suspected acute thromboembolic occlusion of the superior mesenteric artery. Br J Surg 91 (2004), 991–994.
177. Block, T., Nilsson, T.K., Bjorck, M., Acosta, S., Diagnostic accuracy of plasma biomarkers for intestinal ischaemia. Scand J Clin Lab Invest 68 (2008), 242–248.
178. Matsumoto, S., Sekine, K., Funaoka, H., Yamazaki, M., Shimizu, M., Hayashida, K., et al. Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. Br J Surg 101 (2014), 232–238.
179. Cudnik, M.T., Darbha, S., Jones, J., Macedo, J., Stockton, S.W., Hiestand, B.C., The diagnosis of acute mesenteric ischemia: a systematic review and meta-analysis. Acad Emerg Med 20 (2013), 1087–1100.
180. Lehtimaki, T.T., Karkkainen, J.M., Saari, P., Manninen, H., Paajanen, H., Vanninen, R., Detecting acute mesenteric ischemia in CT of the acute abdomen is dependent on clinical suspicion: review of 95 consecutive patients. Eur J Radiol 84 (2015), 2444–2453.
181. Jrvinen, O., Laurikka, J., Salenius, J.P., Tarkka, M., Acute intestinal ischaemia. A review of 214 cases. Ann Chir Gynaecol 83 (1994), 22–25.
182. Beaulieu, R.J., Arnaoutakis, K.D., Abularrage, C.J., Efron, D.T., Schneider, E., Black, J.H. 3rd, Comparison of open and endovascular treatment of acute mesenteric ischemia. J Vasc Surg 59 (2014), 159–164.
183. Bjorck, M., Orr, N., Endean, E.D., Debate: Whether an endovascular-first strategy is the optimal approach for treating acute mesenteric ischemia. J Vasc Surg 62 (2015), 767–772.
184. Block, T.A., Acosta, S., Bjorck, M., Endovascular and open surgery for acute occlusion of the superior mesenteric artery. J Vasc Surg 52 (2010), 959–966.
185. Kalra, M., Ryer, E.J., Oderich, G.S., Duncan, A.A., Bower, T.C., Gloviczki, P., Contemporary results of treatment of acute arterial mesenteric thrombosis: has endovascular treatment improved outcomes?. Perspect Vasc Surg Endovasc Ther 24 (2012), 171–176.
186. Wyers, M.C., Powell, R.J., Nolan, B.W., Cronenwett, J.L., Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia. J Vasc Surg 45 (2007), 269–275.
187. Arthurs, Z.M., Titus, J., Bannazadeh, M., Eagleton, M.J., Srivastava, S., Sarac, T.P., et al. A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg 53 (2011), 698–704.
188. Schermerhorn, M.L., Giles, K.A., Hamdan, A.D., Wyers, M.C., Pomposelli, F.B., Mesenteric revascularization: management and outcomes in the United States, 1988–2006. J Vasc Surg 50 (2009), 341–348.
189. Rotondo, M.F., Schwab, C.W., McGonigal, M.D., Phillips, G.R. 3rd, Fruchterman, T.M., Kauder, D.R., et al. ‘Damage control’: an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 35 (1993), 375–382.
190. Bjorck, M., Acosta, S., Lindberg, F., Troeng, T., Bergqvist, D., Revascularization of the superior mesenteric artery after acute thromboembolic occlusion. Br J Surg 89 (2002), 923–927.
191. Bjornsson, S., Bjorck, M., Block, T., Resch, T., Acosta, S., Thrombolysis for acute occlusion of the superior mesenteric artery. J Vasc Surg 54 (2011), 1734–1742.
192. Thomas, J.H., Blake, K., Pierce, G.E., Hermreck, A.S., Seigel, E., The clinical course of asymptomatic mesenteric arterial stenosis. J Vasc Surg 27 (1998), 840–844.
193. van Petersen, A.S., Meerwaldt, R., Kolkman, J.J., Huisman, A.B., van der Palen, J., van Bockel, J.H., et al. The influence of respiration on criteria for transabdominal duplex examination of the splanchnic arteries in patients with suspected chronic splanchnic ischemia. J Vasc Surg 57 (2013), 1603–1611.
194. Zwolak, R.M., Fillinger, M.F., Walsh, D.B., LaBombard, F.E., Musson, A., Darling, C.E., et al. Mesenteric and celiac duplex scanning: a validation study. J Vasc Surg 27 (1998), 1078–1087.
195. Rheudasil, J.M., Stewart, M.T., Schellack, J.V., Smith, R.B. 3rd, Salam, A.A., Perdue, G.D., Surgical treatment of chronic mesenteric arterial insufficiency. J Vasc Surg 8 (1988), 495–500.
196. Moghadamyeghaneh, Z., Carmichael, J.C., Mills, S.D., Dolich, M.O., Pigazzi, A., Fujitani, R.M., et al. Early outcome of treatment of chronic mesenteric ischemia. Am Surg 81 (2015), 1149–1156.
197. Rawat, N., Gibbons, C.P., Surgical or endovascular treatment for chronic mesenteric ischemia: a multicenter study. Ann Vasc Surg 24 (2010), 935–945.
198. Peck, M.A., Conrad, M.F., Kwolek, C.J., LaMuraglia, G.M., Paruchuri, V., Cambria, R.P., Intermediate-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia. J Vasc Surg 51 (2010), 140–147.
199. Silva, J.A., White, C.J., Collins, T.J., Jenkins, J.S., Andry, M.E., Reilly, J.P., et al. Endovascular therapy for chronic mesenteric ischemia. J Am Coll Cardiol 47 (2006), 944–950.
200. Malgor, R.D., Oderich, G.S., McKusick, M.A., Misra, S., Kalra, M., Duncan, A.A., et al. Results of single- and two-vessel mesenteric artery stents for chronic mesenteric ischemia. Ann Vasc Surg 24 (2010), 1094–1101.
201. Oderich, G.S., Erdoes, L.S., Lesar, C., Mendes, B.C., Gloviczki, P., Cha, S., et al. Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease. J Vasc Surg 58 (2013), 1316–1323.
202. Menke, J., Luthje, L., Kastrup, A., Larsen, J., Thromboembolism in atrial fibrillation. Am J Cardiol 105 (2010), 502–510.
203. Mensink, P.B., van Petersen, A.S., Geelkerken, R.H., Otte, J.A., Huisman, A.B., Kolkman, J.J., Clinical significance of splanchnic artery stenosis. Br J Surg 93 (2006), 1377–1382.
204. Safian, R.D., Textor, S.C., Renal-artery stenosis. N Engl J Med 344 (2001), 431–442.
205. Hirsch, A.T., Haskal, Z.J., Hertzer, N.R., Bakal, C.W., Creager, M.A., Halperin, J.L., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113 (2006), e463–e654.
206. Persu, A., Giavarini, A., Touze, E., Januszewicz, A., Sapoval, M., Azizi, M., et al. European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens 32 (2014), 1367–1378.
207. Tafur-Soto, J.D., White, C.J., Renal artery stenosis. Cardiol Clin 33 (2015), 59–73.
208. Messerli, F.H., Bangalore, S., Makani, H., Rimoldi, S.F., Allemann, Y., White, C.J., et al. Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome. Eur Heart J 32 (2011), 2231–2235.
209. Jennings, C.G., Houston, J.G., Severn, A., Bell, S., Mackenzie, I.S., Macdonald, T.M., Renal artery stenosis-when to screen, what to stent?. Curr Atheroscler Rep, 16, 2014, 416.
210. Zeller, T., Bonvini, R.F., Sixt, S., Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization. Catheter Cardiovasc Interv 71 (2008), 995–999.
211. Williams, G.J., Macaskill, P., Chan, S.F., Karplus, T.E., Yung, W., Hodson, E.M., et al. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol 188 (2007), 798–811.
212. AbuRahma, A.F., Yacoub, M., Renal imaging: duplex ultrasound, computed tomography angiography, magnetic resonance angiography, and angiography. Semin Vasc Surg 26 (2013), 134–143.
213. Tan, K.T., van Beek, E.J., Brown, P.W., van Delden, O.M., Tijssen, J., Ramsay, L.E., Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol 57 (2002), 617–624.
214. De Bruyne, B., Manoharan, G., Pijls, N.H., Verhamme, K., Madaric, J., Bartunek, J., et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol 48 (2006), 1851–1855.
215. Drieghe, B., Madaric, J., Sarno, G., Manoharan, G., Bartunek, J., Heyndrickx, G.R., et al. Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements. Eur Heart J 29 (2008), 517–524.
216. Conlon, P.J., Little, M.A., Pieper, K., Mark, D.B., Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 60 (2001), 1490–1497.
217. Mailloux, L.U., Napolitano, B., Bellucci, A.G., Vernace, M., Wilkes, B.M., Mossey, R.T., Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 24 (1994), 622–629.
218. Catapano, A.L., Graham, I., De Backer, G., Wiklund, O., Chapman, M.J., Drexel, H., et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37 (2016), 2999–3058.
219. Evans, K.L., Tuttle, K.R., Folt, D.A., Dawson, T., Haller, S.T., Brewster, P.S., et al. Use of renin-angiotensin inhibitors in people with renal artery stenosis. Clin J Am Soc Nephrol 9 (2014), 1199–1206.
220. Hackam, D.G., Duong-Hua, M.L., Mamdani, M., Li, P., Tobe, S.W., Spence, J.D., et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J 156 (2008), 549–555.
221. Chrysochou, C., Foley, R.N., Young, J.F., Khavandi, K., Cheung, C.M., Kalra, P.A., Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant 27 (2012), 1403–1409.
222. Losito, A., Errico, R., Santirosi, P., Lupattelli, T., Scalera, G.B., Lupattelli, L., Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant 20 (2005), 1604–1609.
223. Hackam, D.G., Wu, F., Li, P., Austin, P.C., Tobe, S.W., Mamdani, M.M., et al. Statins and renovascular disease in the elderly: a population-based cohort study. Eur Heart J 32 (2011), 598–610.
224. Vashist, A., Heller, E.N., Brown, E.J. Jr., Alhaddad, I.A., Renal artery stenosis: a cardiovascular perspective. Am Heart J 143 (2002), 559–564.
225. Chrysant, G.S., Bates, M.C., Sullivan, T.M., Bachinsky, W.B., Popma, J.J., Peng, L., et al. Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial. J Clin Hypertens (Greenwich) 16 (2014), 497–503.
226. Jaff, M.R., Bates, M., Sullivan, T., Popma, J., Gao, X., Zaugg, M., et al. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial. Catheter Cardiovasc Interv 80 (2012), 343–350.
227. Nordmann, A.J., Woo, K., Parkes, R., Logan, A.G., Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 114 (2003), 44–50.
228. Bavry, A.A., Kapadia, S.R., Bhatt, D.L., Kumbhani, D.J., Renal artery revascularization: updated meta-analysis with the CORAL trial. JAMA Intern Med 174 (2014), 1849–1851.
229. Cooper, C.J., Murphy, T.P., Cutlip, D.E., Jamerson, K., Henrich, W., Reid, D.M., et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 370 (2014), 13–22.
230. Murphy, T.P., Cooper, C.J., Matsumoto, A.H., Cutlip, D.E., Pencina, K.M., Jamerson, K., et al. Renal artery stent outcomes: effect of baseline blood pressure, stenosis severity, and translesion pressure gradient. J Am Coll Cardiol 66 (2015), 2487–2494.
231. Wheatley, K., Ives, N., Gray, R., Kalra, P.A., Moss, J.G., Baigent, C., et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 361 (2009), 1953–1962.
232. Bax, L., Woittiez, A.J., Kouwenberg, H.J., Mali, W.P., Buskens, E., Beek, F.J., et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 150 (2009), 840–848.
233. Olin, J.W., Gornik, H.L., Bacharach, J.M., Biller, J., Fine, L.J., Gray, B.H., et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation 129 (2014), 1048–1078.
234. Davies, M.G., Saad, W.E., Peden, E.K., Mohiuddin, I.T., Naoum, J.J., Lumsden, A.B., The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg 48 (2008), 865–871.
235. Mousa, A.Y., Campbell, J.E., Stone, P.A., Broce, M., Bates, M.C., AbuRahma, A.F., Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. J Vasc Surg 55 (2012), 421–427.
236. Trinquart, L., Mounier-Vehier, C., Sapoval, M., Gagnon, N., Plouin, P.F., Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 56 (2010), 525–532.
237. Kane, G.C., Xu, N., Mistrik, E., Roubicek, T., Stanson, A.W., Garovic, V.D., Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant 25 (2010), 813–820.
238. Ritchie, J., Green, D., Chrysochou, C., Chalmers, N., Foley, R.N., Kalra, P.A., High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. Am J Kidney Dis 63 (2014), 186–197.
239. van den Berg, D.T., Deinum, J., Postma, C.T., van der Wilt, G.J., Riksen, N.P., The efficacy of renal angioplasty in patients with renal artery stenosis and flash oedema or congestive heart failure: a systematic review. Eur J Heart Fail 14 (2012), 773–781.
240. Cianci, R., Martina, P., Borghesi, F., di Donato, D., Polidori, L., Lai, S., et al. Revascularization versus medical therapy for renal artery stenosis: antihypertensive drugs and renal outcome. Angiology 62 (2011), 92–99.
241. Abela, R., Ivanova, S., Lidder, S., Morris, R., Hamilton, G., An analysis comparing open surgical and endovascular treatment of atherosclerotic renal artery stenosis. Eur J Vasc Endovasc Surg 38 (2009), 666–675.
242. Balzer, K.M., Neuschafer, S., Sagban, T.A., Grotemeyer, D., Pfeiffer, T., Rump, L.C., et al. Renal artery revascularization after unsuccessful percutaneous therapy: a single centre experience. Langenbecks Arch Surg 397 (2012), 111–115.
243. Balzer, K.M., Pfeiffer, T., Rossbach, S., Voiculescu, A., Modder, U., Godehardt, E., et al. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD). J Vasc Surg 49 (2009), 667–674.
244. McDermott, M.M., Greenland, P., Liu, K., Guralnik, J.M., Criqui, M.H., Dolan, N.C., et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 286 (2001), 1599–1606.
245. Leng, G.C., Fowkes, F.G., The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 45 (1992), 1101–1109.
246. Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., Fowkes, F.G., Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45:Suppl. S (2007), S5–S67.
247. Abou-Zamzam, A.M. Jr., Gomez, N.R., Molkara, A., Banta, J.E., Teruya, T.H., Killeen, J.D., et al. A prospective analysis of critical limb ischemia: factors leading to major primary amputation versus revascularization. Ann Vasc Surg 21 (2007), 458–463.
248. Abu Dabrh, A.M., Steffen, M.W., Undavalli, C., Asi, N., Wang, Z., Elamin, M.B., et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg 62 (2015), 1642–1651.
249. Sigvant, B., Lundin, F., Wahlberg, E., The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg 51 (2016), 395–403.
250. Xu, D., Zou, L., Xing, Y., Hou, L., Wei, Y., Zhang, J., et al. Diagnostic value of ankle-brachial index in peripheral arterial disease: a meta-analysis. Can J Cardiol 29 (2013), 492–498.
251. Aboyans, V., Criqui, M.H., Abraham, P., Allison, M.A., Creager, M.A., Diehm, C., et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 126 (2012), 2890–2909.
252. Tehan, P.E., Santos, D., Chuter, V.H., A systematic review of the sensitivity and specificity of the toe-brachial index for detecting peripheral artery disease. Vasc Med 21 (2016), 382–389.
253. Collins, R., Cranny, G., Burch, J., Aguiar-Ibanez, R., Craig, D., Wright, K., et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess 11 (2007), 1–184.
254. Met, R., Bipat, S., Legemate, D.A., Reekers, J.A., Koelemay, M.J., Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 301 (2009), 415–424.
255. Menke, J., Larsen, J., Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease. Ann Intern Med 153 (2010), 325–334.
256. Koelemay, M.J., Lijmer, J.G., Stoker, J., Legemate, D.A., Bossuyt, P.M., Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA 285 (2001), 1338–1345.
257. Ouwendijk, R., de Vries, M., Stijnen, T., Pattynama, P.M., van Sambeek, M.R., Buth, J., et al. Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial. AJR Am J Roentgenol 190 (2008), 1349–1357.
258. Barba, A., Estallo, L., Rodriguez, L., Baquer, M., Vega de Ceniga, M., Detection of abdominal aortic aneurysm in patients with peripheral artery disease. Eur J Vasc Endovasc Surg 30 (2005), 504–508.
259. Giugliano, G., Laurenzano, E., Rengo, C., De Rosa, G., Brevetti, L., Sannino, A., et al. Abdominal aortic aneurysm in patients affected by intermittent claudication: prevalence and clinical predictors. BMC Surg, 12(Suppl. 1), 2012, S17.
260. Juergens, J.L., Barker, N.W., Hines, E.A. Jr., Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 21 (1960), 188–195.
261. Momsen, A.H., Jensen, M.B., Norager, C.B., Madsen, M.R., Vestersgaard-Andersen, T., Lindholt, J.S., Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg 38 (2009), 463–474.
262. Shahin, Y., Barnes, R., Barakat, H., Chetter, I.C., Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication. Atherosclerosis 231 (2013), 283–290.
263. Vlachopoulos, C., Terentes-Printzios, D., Aboyans, V., Brodmann, M., De Carlo, M., Tousoulis, D., Angiotensin converting enzyme inhibitors and walking distance: have we walked the whole distance?. Atherosclerosis 252 (2016), 199–200.
264. Bagger, J.P., Helligsoe, P., Randsbaek, F., Kimose, H.H., Jensen, B.S., Effect of verapamil in intermittent claudication A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment. Circulation 95 (1997), 411–414.
265. Espinola-Klein, C., Weisser, G., Jagodzinski, A., Savvidis, S., Warnholtz, A., Ostad, M.A., et al. Beta-blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial. Hypertension 58 (2011), 148–154.
266. Soga, Y., Iida, O., Takahara, M., Hirano, K., Suzuki, K., Kawasaki, D., Beta-blocker treatment does not worsen critical limb ischemia in patients receiving endovascular therapy. J Atheroscler Thromb 22 (2015), 481–489.
267. Mirault, T.G.A., Cambou, J.P., Lacroix, P., Aboyans, V., Boulon, C., Constans, J., et al. Impact of beta-blockers on general and local outcome in patients hospitalized for lower extremity peripheral artery disease. The COPART Registry. Medicine (Baltimore), 96, 2017, e5916.
268. Lane, R., Ellis, B., Watson, L., Leng, G.C., Exercise for intermittent claudication. Cochrane Database Syst Rev, 7, 2014, CD000990.
269. Fokkenrood, H.J., Bendermacher, B.L., Lauret, G.J., Willigendael, E.M., Prins, M.H., Teijink, J.A., Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev, 8, 2013, CD005263.
270. Gommans, L.N., Fokkenrood, H.J., van Dalen, H.C., Scheltinga, M.R., Teijink, J.A., Peters, R.J., Safety of supervised exercise therapy in patients with intermittent claudication. J Vasc Surg 61 (2015), 512–518.
271. Bermingham, S.L., Sparrow, K., Mullis, R., Fox, M., Shearman, C., Bradbury, A., et al. The cost-effectiveness of supervised exercise for the treatment of intermittent claudication. Eur J Vasc Endovasc Surg 46 (2013), 707–714.
272. Al-Jundi, W., Madbak, K., Beard, J.D., Nawaz, S., Tew, G.A., Systematic review of home-based exercise programmes for individuals with intermittent claudication. Eur J Vasc Endovasc Surg 46 (2013), 690–706.
273. Back, M., Jivegard, L., Johansson, A., Nordanstig, J., Svanberg, T., Adania, U.W., et al. Home-based supervised exercise versus hospital-based supervised exercise or unsupervised walk advice as treatment for intermittent claudication: a systematic review. J Rehabil Med 47 (2015), 801–808.
274. Lauret, G.J., Fakhry, F., Fokkenrood, H.J., Hunink, M.G., Teijink, J.A., Spronk, S., Modes of exercise training for intermittent claudication. Cochrane Database Syst Rev, 7, 2014, CD009638.
275. Jakubseviciene, E., Vasiliauskas, D., Velicka, L., Kubilius, R., Milinaviciene, E., Vencloviene, J., Effectiveness of a new exercise program after lower limb arterial blood flow surgery in patients with peripheral arterial disease: a randomized clinical trial. Int J Environ Res Public Health 11 (2014), 7961–7976.
276. Kruidenier, L.M., Nicolai, S.P., Rouwet, E.V., Peters, R.J., Prins, M.H., Teijink, J.A., Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial. J Vasc Interv Radiol 22 (2011), 961–968.
277. Gargiulo, G., Giugliano, G., Brevetti, L., Sannino, A., Schiattarella, G.G., Serino, F., et al. Use of statins in lower extremity artery disease: a review. BMC Surg, 12(Suppl. 1), 2012, S15.
278. McDermott, M.M., Guralnik, J.M., Greenland, P., Pearce, W.H., Criqui, M.H., Liu, K., et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation 107 (2003), 757–761.
279. Robertson, L., Andras, A., Prostanoids for intermittent claudication. Cochrane Database Syst Rev, 4, 2013, CD000986.
280. Stevens, J.W., Simpson, E., Harnan, S., Squires, H., Meng, Y., Thomas, S., et al. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication. Br J Surg 99 (2012), 1630–1638.
281. Indes, J.E., Pfaff, M.J., Farrokhyar, F., Brown, H., Hashim, P., Cheung, K., et al. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther 20 (2013), 443–455.
282. Grimme, F.A., Goverde, P.C., Verbruggen, P.J., Zeebregts, C.J., Reijnen, M.M., Editor's choice—first results of the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for aortoiliac occlusive disease. Eur J Vasc Endovasc Surg 50 (2015), 638–647.
283. Anderson, J.L., Antman, E.M., Harold, J.G., Jessup, M., O'Gara, P.T., Pinto, F.J., et al. Clinical practice guidelines on perioperative cardiovascular evaluation: collaborative efforts among the ACC, AHA, and ESC. Circulation 130 (2014), 2213–2214.
284. Klinkert, P., Post, P.N., Breslau, P.J., van Bockel, J.H., Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 27 (2004), 357–362.
285. Malgor, R.D., Alahdab, F., Elraiyah, T.A., Rizvi, A.Z., Lane, M.A., Prokop, L.J., et al. A systematic review of treatment of intermittent claudication in the lower extremities. J Vasc Surg 61:Suppl. 3 (2015), 54s–73s.
286. Murphy, T.P., Cutlip, D.E., Regensteiner, J.G., Mohler, E.R., Cohen, D.J., Reynolds, M.R., et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) study. Circulation 125 (2012), 130–139.
287. Bendermacher, B.L., Willigendael, E.M., Teijink, J.A., Prins, M.H., Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev, 2, 2006, CD005263.
288. Fakhry, F., Spronk, S., van der Laan, L., Wever, J.J., Teijink, J.A., Hoffmann, W.H., et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA 314 (2015), 1936–1944.
289. Vemulapalli, S., Dolor, R.J., Hasselblad, V., Schmit, K., Banks, A., Heidenfelder, B., et al. Supervised vs unsupervised exercise for intermittent claudication: a systematic review and meta-analysis. Am Heart J 169 (2015), 924–937.
290. Greenhalgh, R.M., Belch, J.J., Brown, L.C., Gaines, P.A., Gao, L., Reise, J.A., et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg 36 (2008), 680–688.
291. Jongkind, V., Akkersdijk, G.J., Yeung, K.K., Wisselink, W., A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg 52 (2010), 1376–1383.
292. Ballotta, E., Lorenzetti, R., Piatto, G., Tolin, F., Da Giau, G., Toniato, A., Reconstructive surgery for complex aortoiliac occlusive disease in young adults. J Vasc Surg 56 (2012), 1606–1614.
293. Bredahl, K., Jensen, L.P., Schroeder, T.V., Sillesen, H., Nielsen, H., Eiberg, J.P., Mortality and complications after aortic bifurcated bypass procedures for chronic aortoiliac occlusive disease. J Vasc Surg 62 (2015), 75–82.
294. Bosiers, M., Deloose, K., Callaert, J., Maene, L., Beelen, R., Keirse, K., et al. BRAVISSIMO: 12-month results from a large scale prospective trial. J Cardiovasc Surg (Torino) 54 (2013), 235–253.
295. Ye, W., Liu, C.W., Ricco, J.B., Mani, K., Zeng, R., Jiang, J., Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg 53 (2011), 1728–1737.
296. Goode, S.D.C.T., Gaines, P.A., Randomized clinical trial of stents versus angioplasty for the treatment of iliac artery occlusions (STAG trial). Br J Surg 100 (2013), 1148–1153.
297. Antoniou, G.A., Sfyroeras, G.S., Karathanos, C., Achouhan, H., Koutsias, S., Vretzakis, G., et al. Hybrid endovascular and open treatment of severe multilevel lower extremity arterial disease. Eur J Vasc Endovasc Surg 38 (2009), 616–622.
298. Dosluoglu, H.H., Lall, P., Cherr, G.S., Harris, L.M., Dryjski, M.L., Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease. J Vasc Surg 51 (2010), 1425–1435.
299. Kavanagh, C.M., Heidenreich, M.J., Albright, J.J., Aziz, A., Hybrid external iliac selective endarterectomy surgical technique and outcomes. J Vasc Surg 64 (2016), 1327–1334.
300. Matsagkas, M., Kouvelos, G., Arnaoutoglou, E., Papa, N., Labropoulos, N., Tassiopoulos, A., Hybrid procedures for patients with critical limb ischemia and severe common femoral artery atherosclerosis. Ann Vasc Surg 25 (2011), 1063–1069.
301. Crawford, J.D., Perrone, K.H., Wong, V.W., Mitchell, E.L., Azarbal, A.F., Liem, T.K., et al. A modern series of acute aortic occlusion. J Vasc Surg 59 (2014), 1044–1050.
302. Lammer, J., Zeller, T., Hausegger, K.A., Schaefer, P.J., Gschwendtner, M., Mueller-Huelsbeck, S., et al. Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial. Cardiovasc Intervent Radiol 38 (2015), 25–32.
303. Lammer, J., Zeller, T., Hausegger, K.A., Schaefer, P.J., Gschwendtner, M., Mueller-Huelsbeck, S., et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol 62 (2013), 1320–1327.
304. Laird, J.R., Katzen, B.T., Scheinert, D., Lammer, J., Carpenter, J., Buchbinder, M., et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther 19 (2012), 1–9.
305. Schillinger, M., Sabeti, S., Dick, P., Amighi, J., Mlekusch, W., Schlager, O., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115 (2007), 2745–2749.
306. Liistro, F., Grotti, S., Porto, I., Angioli, P., Ricci, L., Ducci, K., et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv 6 (2013), 1295–1302.
307. Rosenfield, K., Jaff, M.R., White, C.J., Rocha-Singh, K., Mena-Hurtado, C., Metzger, D.C., et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 373 (2015), 145–153.
308. Tepe, G., Laird, J., Schneider, P., Brodmann, M., Krishnan, P., Micari, A., et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 131 (2015), 495–502.
309. Tepe, G., Zeller, T., Albrecht, T., Heller, S., Schwarzwalder, U., Beregi, J.P., et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358 (2008), 689–699.
310. Werk, M., Albrecht, T., Meyer, D.R., Ahmed, M.N., Behne, A., Dietz, U., et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv 5 (2012), 831–840.
311. Geraghty, P.J., Mewissen, M.W., Jaff, M.R., Ansel, G.M., Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 58 (2013), 386–395.
312. Scheinert, D., Werner, M., Scheinert, S., Paetzold, A., Banning-Eichenseer, U., Piorkowski, M., et al. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. JACC Cardiovasc Interv 6 (2013), 65–71.
313. Tosaka, A., Soga, Y., Iida, O., Ishihara, T., Hirano, K., Suzuki, K., et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 59 (2012), 16–23.
314. Bradbury, A.W., Adam, D.J., Bell, J., Forbes, J.F., Fowkes, F.G., Gillespie, I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 51:Suppl. 5 (2010), 52s–68s.
315. Arvela, E., Venermo, M., Soderstrom, M., Alback, A., Lepantalo, M., Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk. Ann Vasc Surg 26 (2012), 396–403.
316. Brass, E.P., Anthony, R., Dormandy, J., Hiatt, W.R., Jiao, J., Nakanishi, A., et al. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg 43 (2006), 752–759.
317. Mills, J.L. Sr., Conte, M.S., Armstrong, D.G., Pomposelli, F.B., Schanzer, A., Sidawy, A.N., et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 59 (2014), 220–234.e2.
318. Singh, S., Armstrong, E.J., Sherif, W., Alvandi, B., Westin, G.G., Singh, G.D., et al. Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty. Vasc Med 19 (2014), 307–314.
319. Takahara, M., Kaneto, H., Iida, O., Gorogawa, S., Katakami, N., Matsuoka, T.A., et al. The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia. Diabetes Care 33 (2010), 2538–2542.
320. Dominguez, A. 3rd, Bahadorani, J., Reeves, R., Mahmud, E., Patel, M., Endovascular therapy for critical limb ischemia. Expert Rev Cardiovasc Ther 13 (2015), 429–444.
321. Lumsden, A.B., Davies, M.G., Peden, E.K., Medical and endovascular management of critical limb ischemia. J Endovasc Ther 16:2 Suppl. 2 (2009), 31–62.
322. Manzi, M., Palena, L., Cester, G., Endovascular techniques for limb salvage in diabetics with crural and pedal disease. J Cardiovasc Surg (Torino) 52 (2011), 485–492.
323. Adam, D.J., Beard, J.D., Cleveland, T., Bell, J., Bradbury, A.W., Forbes, J.F., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005), 1925–1934.
324. Zeller, T., Baumgartner, I., Scheinert, D., Brodmann, M., Bosiers, M., Micari, A., et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol 64 (2014), 1568–1576.
325. Menard, M.T., Farber, A., The BEST-CLI trial: a multidisciplinary effort to assess whether surgical or endovascular therapy is better for patients with critical limb ischemia. Semin Vasc Surg 27 (2014), 82–84.
326. Popplewell, M.A., Davies, H., Jarrett, H., Bate, G., Grant, M., Patel, S., et al. Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: study protocol for a randomised controlled trial. Trials, 17, 2016, 11.
327. Teraa, M., Conte, M.S., Moll, F.L., Verhaar, M.C., Critical limb ischemia: current trends and future directions. J Am Heart Assoc, 5, 2016, e002938.
328. Belch, J., Hiatt, W.R., Baumgartner, I., Driver, I.V., Nikol, S., Norgren, L., et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 377 (2011), 1929–1937.
329. Moazzami, K., Moazzami, B., Roohi, A., Nedjat, S., Dolmatova, E., Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia. Cochrane Database Syst Rev, 12, 2014, CD008347.
330. Peeters Weem, S.M., Teraa, M., de Borst, G.J., Verhaar, M.C., Moll, F.L., Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials. Eur J Vasc Endovasc Surg 50 (2015), 775–783.
331. Sobel, M., Verhaeghe, R., Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133:Suppl. 6 (2008), 815s–843s.
332. Rutherford, R.B., Baker, J.D., Ernst, C., Johnston, K.W., Porter, J.M., Ahn, S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997), 517–538.
333. Berridge, D.C., Kessel, D., Robertson, I., Surgery versus thrombolysis for acute limb ischaemia: initial management. Cochrane Database Syst Rev, 3, 2002, CDd002784.
334. Savji, N., Rockman, C.B., Skolnick, A.H., Guo, Y., Adelman, M.A., Riles, T., et al. Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects. J Am Coll Cardiol 61 (2013), 1736–1743.
335. Aboyans, V., Desormais, I., Magne, J., Morange, G., Mohty, D., Lacroix, P., Renal Artery stenosis in patients with peripheral artery disease: prevalence, risk factors and long-term prognosis. Eur J Vasc Endovasc Surg 53 (2016), 380–385.
336. Aboyans, V., Polyvascular disease: definition, epidemiology, relevance. Lanzer, P., (eds.) PanVascular Medicine, 2nd ed, 2015, Springer, Berlin, 4779–4810.
337. Ahmed, B., Al-Khaffaf, H., Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: a meta-analysis. Eur J Vasc Endovasc Surg 37 (2009), 262–271.
338. Durand, D.J., Perler, B.A., Roseborough, G.S., Grega, M.A., Borowicz, L.M. Jr., Baumgartner, W.A., et al. Mandatory versus selective preoperative carotid screening: a retrospective analysis. Ann Thorac Surg 78 (2004), 159–166 [discussion 159–66].
339. Fowkes, F.G., Low, L.P., Tuta, S., Kozak, J., Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study. Eur Heart J 27 (2006), 1861–1867.
340. Mukherjee, D., Eagle, K.A., Kline-Rogers, E., Feldman, L.J., Juliard, J.M., Agnelli, G., et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol 100 (2007), 1–6.
341. Naylor, A.R., Mehta, Z., Rothwell, P.M., Bell, P.R., Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg 23 (2002), 283–294.
342. Steinvil, A., Sadeh, B., Arbel, Y., Justo, D., Belei, A., Borenstein, N., et al. Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. J Am Coll Cardiol 57 (2011), 779–783.
343. Subherwal, S., Bhatt, D.L., Li, S., Wang, T.Y., Thomas, L., Alexander, K.P., et al. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes 5 (2012), 541–549.
344. Collet JP, Cayla G, Ennezat PV, Leclercq F, Cuisset T, Elhadad S, et al; for the AMERICA Investigators. Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: the randomized AMERICA Study [submitted].
345. Lin, J.C., Kabbani, L.S., Peterson, E.L., Masabni, K., Morgan, J.A., Brooks, S., et al. Clinical utility of carotid duplex ultrasound prior to cardiac surgery. J Vasc Surg 63 (2016), 710–714.
346. Masabni, K.R.S., Blackstone, E.H., Gornik, H.L., Sabik, J.F. 3rd, Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting?. J Thorac Cardiovasc Surg 149 (2015), 1253–1260.
347. Naylor, A.R., Bown, M.J., Stroke after cardiac surgery and its association with asymptomatic carotid disease: an updated systematic review and meta-analysis. Eur J Vasc Endovasc Surg 41 (2011), 607–624.
348. Schoof, J., Lubahn, W., Baeumer, M., Kross, R., Wallesch, C.W., Kozian, A., et al. Impaired cerebral autoregulation distal to carotid stenosis/occlusion is associated with increased risk of stroke at cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 134 (2007), 690–696.
349. Stamou, S.C., Hill, P.C., Dangas, G., Pfister, A.J., Boyce, S.W., Dullum, M.K., et al. Stroke after coronary artery bypass: incidence, predictors, and clinical outcome. Stroke 32 (2001), 1508–1513.
350. Naylor, A.R., Delay may reduce procedural risk, but at what price to the patient?. Eur J Vasc Endovasc Surg 35 (2008), 383–391.
351. Lamy, A., Devereaux, P.J., Prabhakaran, D., Taggart, D.P., Hu, S., Paolasso, E., et al., CORONARY Investigators. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med 366 (2012), 1489–1497.
352. Illuminati, G., Ricco, J.B., Calio, F., Pacile, M.A., Miraldi, F., Frati, G., et al. Short-term results of a randomized trial examining timing of carotid endarterectomy in patients with severe asymptomatic unilateral carotid stenosis undergoing coronary artery bypass grafting. J Vasc Surg 54 (2011), 993–999.
353. Randall, M.S., McKevitt, F., Cleveland, T.J., Gaines, P.A., Venables, G.S., Is there any benefit from staged carotid and coronary revascularization using carotid stents? A single-center experience highlights the need for a randomized controlled trial. Stroke 37 (2006), 435–439.
354. Van der Heyden, J.S.M., Bal, E.T., Ernst, J.M., Ackerstaff, R.G., Schaap, J., Kelder, J.C., et al. Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term results. Circulation 116 (2007), 2036–2342.
355. Versaci, F., Del Giudice, C., Scafuri, A., Zeitani, J., Gandini, R., Nardi, P., et al. Sequential hybrid carotid and coronary artery revascularization: immediate and mid-term results. Ann Thorac Surg 84 (2007), 1508–1513.
356. Chiariello, L.N.P., Pellegrino, A., Saitto, G., Chiariello, G.A., Russo, M., Zeitani, J., et al. Simultaneous carotid artery stenting and heart surgery: expanded experience of hybrid surgical procedures. Ann Thorac Surg 99 (2015), 1291–1297.
357. Shishehbor, M.H., Venkatachalam, S., Sun, Z., Rajeswaran, J., Kapadia, S.R., Bajzer, C., et al. A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. J Am Coll Cardiol 62 (2013), 1948–1956.
358. Aboyans, V., Lacroix, P., Indications for carotid screening in patients with coronary artery disease. Presse Med 38 (2009), 977–986.
359. Naylor, A.R., Cuffe, R.L., Rothwell, P.M., Bell, P.R., A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass. Eur J Vasc Endovasc Surg 25 (2003), 380–389.
360. Paraskevas, K.I., Nduwayo, S., Saratzis, A.N., Naylor, A.R., Carotid stenting prior to coronary bypass surgery: an updated systematic review and meta-analysis. Eur J Vasc Endovasc Surg 53 (2017), 309–319.
361. Imori, Y., Akasaka, T., Ochiai, T., Oyama, K., Tobita, K., Shishido, K., et al. Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease. Am J Cardiol 113 (2014), 30–35.
362. Kim, E.K.S.P., Yang, J.H., Song, Y.B., Hahn, J.Y., Choi, J.H., Gwon, H.C., et al. Peripheral artery disease in Korean patients undergoing percutaneous coronary intervention: prevalence and association with coronary artery disease severity. J Korean Med Sci 28 (2013), 87–92.
363. Hussein, A.A.U.K., Wolski, K., Kapadia, S., Schoenhagen, P., Tuzcu, E.M., Nissen, S.E., et al. Peripheral arterial disease and progression of coronary atherosclerosis. J Am Coll Cardiol 57 (2011), 1220–1225.
364. Eagle, K.A., Rihal, C.S., Foster, E.D., Mickel, M.C., Gersh, B.J., Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators. J Am Coll Cardiol 23 (1994), 1091–1095.
365. Grenon, S.M., Vittinghoff, E., Owens, C.D., Conte, M.S., Whooley, M., Cohen, B.E., Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study. Vasc Med 18 (2013), 176–184.
366. Saw, J., Bhatt, D.L., Moliterno, D.J., Brener, S.J., Steinhubl, S.R., Lincoff, A.M., et al. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol 48 (2006), 1567–1572.
367. Aboyans, V., Lacroix, P., Postil, A., Guilloux, J., Rolle, F., Cornu, E., et al. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 46 (2005), 815–820.
368. Rihal, C.S., Sutton-Tyrrell, K., Guo, P., Keller, N.M., Jandova, R., Sellers, M.A., et al. Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation. Circulation 100 (1999), 171–177.
369. Hlatky, M.A., Boothroyd, D.B., Baker, L., Kazi, D.S., Solomon, M.D., Chang, T.I., et al. Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Ann Intern Med 158 (2013), 727–734.
370. Farooq, V., van Klaveren, D., Steyerberg, E.W., Meliga, E., Vergouwe, Y., Chieffo, A., et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381 (2013), 639–650.
371. Dencker, D., Pederson, F., Engstrom, T., Kober, L., Hojberg, S., Nielsen, M.B., et al. Major femoral vascular access complications after coronary diagnostic and interventional procedures: a Danish register study. Int J Cardiol 202 (2016), 604–608.
372. Neufang, A., Dorweiler, B., Espinola-Klein, C., Savvidis, S., Doemland, M., Schotten, S., et al. Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts. J Vasc Surg 60 (2014), 1543–1553.
373. Spronk, S., White, J.V., Ryjewski, C., Rosenblum, J., Bosch, J.L., Hunink, M.G., Invasive treatment of claudication is indicated for patients unable to adequately ambulate during cardiac rehabilitation. J Vasc Surg 49 (2009), 1217–1225.
374. Aboyans, V., Lacroix, P., Guilloux, J., Rolle, F., Le Guyader, A., Cautres, M., et al. A predictive model for screening cerebrovascular disease in patient undergoing coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 4 (2005), 90–95.
375. Valgimigli, M., Gagnor, A., Calabro, P., Frigoli, E., Leonardi, S., Zaro, T., et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet 385 (2015), 2465–2476.
376. Jones, W.S., Clare, R., Ellis, S.J., Mills, J.S., Fischman, D.L., Kraus, W.E., et al. Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION). Am J Cardiol 108 (2011), 380–384.
377. Inglis, S.C., Bebchuk, J., Al-Suhaim, S.A., Case, J., Pfeffer, M.A., Solomon, S.D., et al. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. Int J Cardiol 168 (2013), 1094–1101.
378. Nakamura, Y., Kunii, H., Yoshihisa, A., Takiguchi, M., Shimizu, T., Yamauchi, H., et al. Impact of peripheral artery disease on prognosis in hospitalized heart failure patients. Circ J 79 (2015), 785–793.
379. van Straten, A.H., Firanescu, C., Soliman Hamad, M.A., Tan, M.E., ter Woorst, J.F., Martens, E.J., et al. Peripheral vascular disease as a predictor of survival after coronary artery bypass grafting: comparison with a matched general population. Ann Thorac Surg 89 (2010), 414–420.
380. Calvet, D., Touze, E., Varenne, O., Sablayrolles, J.L., Weber, S., Mas, J.L., Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study. Circulation 121 (2010), 1623–1629.
381. Hofmann, R., Kypta, A., Steinwender, C., Kerschner, K., Grund, M., Leisch, F., Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease. Heart 91 (2005), 1438–1441.
382. Illuminati, G., Ricco, J.B., Greco, C., Mangieri, E., Calio, F., Ceccanei, G., et al. Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial. Eur J Vasc Endovasc Surg 39 (2010), 139–145.
383. Illuminati, G., Schneider, F., Greco, C., Mangieri, E., Schiariti, M., Tanzilli, G., et al. Long-term results of a randomized controlled trial analyzing the role of systematic pre-operative coronary angiography before elective carotid endarterectomy in patients with asymptomatic coronary artery disease. Eur J Vasc Endovasc Surg 49 (2015), 366–774.
384. Vidakovic, R., Schouten, O., Kuiper, R., Hoeks, S.E., Flu, W.J., van Kuijk, J.P., et al. The prevalence of polyvascular disease in patients referred for peripheral arterial disease. Eur J Vasc Endovasc Surg 38 (2009), 435–440.
385. Hur, D.J., Kizilgul, M., Aung, W.W., Roussillon, K.C., Keeley, E.C., Frequency of coronary artery disease in patients undergoing peripheral artery disease surgery. Am J Cardiol 110 (2012), 736–740.
386. Ishihara, T., Iida, O., Tosaka, A., Soga, Y., Sakamoto, Y., Hirano, K., et al. Severity of coronary artery disease affects prognosis of patients with peripheral artery disease. Angiology 64 (2013), 417–422.
387. Kristensen, S.D., Knuuti, J., Saraste, A., Anker, S., Botker, H.E., De Hert, S., et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 31 (2014), 517–573.
388. Gallino, A., Aboyans, V., Diehm, C., Cosentino, F., Stricker, H., Falk, E., et al. Non-coronary atherosclerosis. Eur Heart J 35 (2014), 1112–1119.
389. Cho, I., Chang, H., Sung, J.M., Pencina, M.J., Lin, F.Y., Dunning, A.M., et al., CONFIRM Investigators. Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes: an international multicenter registry). Circulation 126 (2012), 304–313.
390. Bhatt, D.L., Peterson, E.D., Harrington, R.A., Ou, F.S., Cannon, C.P., Gibson, C.M., et al., CRUSADE Investigators. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J 30 (2009), 1195–1202.
391. Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34 (2013), 2949–3003.
392. Sirimarco, G., Amarenco, P., Labreuche, J., Touboul, P.J., Alberts, M., Goto, S., et al., REACH Registry Investigators. Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis. Stroke 44 (2013), 373–379.
393. Amighi, J., Schlager, O., Haumer, M., Dick, P., Mlekusch, W., Loewe, C., et al. Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease. Eur J Clin Invest 39 (2009), 784–792.
394. Rauchhaus, M., Doehner, W., Francis, D.P., Davos, C., Kemp, M., Liebenthal, C., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000), 3060–3067.
395. Kahan, T., The importance of myocardial fibrosis in hypertensive heart disease. J Hypertens 30 (2012), 685–687.
396. O'Rourke, M.F., Safar, M.E., Dzau, V., The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc Med 15 (2010), 461–468.
397. Duscha, B.D., Annex, B.H., Green, H.J., Pippen, A.M., Kraus, W.E., Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure. J Am Coll Cardiol 39 (2002), 1170–1174.
398. Mancini, D.M., Walter, G., Reichek, N., Lenkinski, R., McCully, K.K., Mullen, J.L., et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85 (1992), 1364–1373.
399. Hedberg, P., Hammar, C., Selmeryd, J., Viklund, J., Leppert, J., Hellberg, A., et al. Left ventricular systolic dysfunction in outpatients with peripheral atherosclerotic vascular disease: prevalence and association with location of arterial disease. Eur J Heart Fail 16 (2014), 625–632.
400. Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G., Coats, A.J., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18 (2016), 891–975.
401. Yamasaki, S., Izawa, A., Shiba, Y., Tomita, T., Miyashita, Y., Koyama, J., et al. Presence of diastolic dysfunction in patients with peripheral artery disease. Angiology 64 (2013), 540–543.
402. Meltzer, A.J., Shrikhande, G., Gallagher, K.A., Aiello, F.A., Kahn, S., Connolly, P., et al. Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease. J Vasc Surg 55 (2012), 353–362.
403. Inglis, S.C., Hermis, A., Shehab, S., Newton, P.J., Lal, S., Davidson, P.M., Peripheral arterial disease and chronic heart failure: a dangerous mix. Heart Fail Rev 18 (2013), 457–664.
404. Inglis, S.C., McMurray, J.J., Bohm, M., Schaufelberger, M., van Veldhuisen, D.J., Lindberg, M., et al. Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). Eur J Heart Fail 12 (2010), 698–705.
405. Ahmed, M.I., Aronow, W.S., Criqui, M.H., Aban, I., Love, T.E., Eichhorn, E.J., et al. Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched study. Circ Heart Fail 3 (2010), 118–124.
406. Go, A.S., Hylek, E.M., Phillips, K.A., Chang, Y., Henault, L.E., Selby, J.V., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001), 2370–2375.
407. Griffin, W.F., Salahuddin, T., O'Neal, W.T., Soliman, E.Z., Peripheral arterial disease is associated with an increased risk of atrial fibrillation in the elderly. Europace 18 (2016), 794–798.
408. Aboyans, V., Lacroix, P., Echahidi, N., Mohty, D., Ankle-brachial index in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol 63 (2014), 1456–1457.
409. Gallego, P., Roldan, V., Marin, F., Jover, E., Manzano-Fernandez, S., Valdes, M., et al. Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation. Eur J Clin Invest 42 (2012), 1302–1308.
410. O'Neal, W.T., Efird, J.T., Nazarian, S., Alonso, A., Heckbert, S.R., Soliman, E.Z., Peripheral arterial disease and risk of atrial fibrillation and stroke: the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc, 3, 2014, e001270.
411. Wasmer, K., Unrath, M., Kobe, J., Malyar, N.M., Freisinger, E., Meyborg, M., et al. Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease. Int J Cardiol 199 (2015), 223–228.
412. euroSCORE interactive calculator. http://www.euroscore.org/calc.html.
413. Gilard, M., Eltchaninoff, H., Iung, B., Donzeau-Gouge, P., Chevreul, K., Fajadet, J., et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 366 (2012), 1705–1715.
414. Leon, M.B., Smith, C.R., Mack, M., Miller, D.C., Moses, J.W., Svensson, L.G., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363 (2010), 1597–1607.
415. Skelding, K.A., Yakubov, S.J., Kleiman, N.S., Reardon, M.J., Adams, D.H., Huang, J., et al. Transcatheter aortic valve replacement versus surgery in women at high risk for surgical aortic valve replacement (from the CoreValve US High Risk Pivotal Trial). Am J Cardiol 118 (2016), 560–566.
416. Aronow, W.S., Peripheral arterial disease in the elderly. Clin Interv Aging 2 (2007), 645–654.
417. Adams, D.H., Popma, J.J., Reardon, M.J., Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 371 (2014), 967–968.
418. Smith, C.R., Leon, M.B., Mack, M.J., Miller, D.C., Moses, J.W., Svensson, L.G., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364 (2011), 2187–2198.
419. Sinning, J.M., Horack, M., Grube, E., Gerckens, U., Erbel, R., Eggebrecht, H., et al. The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry. Am Heart J 164 (2012), 102–110.
420. Erdogan, H.B., Goksedef, D., Erentug, V., Polat, A., Bozbuga, N., Mansuroglu, D., et al. In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases. J Card Surg 21 (2006), 342–346.
421. Ohman, J.W., Vemuri, C., Prasad, S., Silvestry, S.C., Jim, J., Geraghty, P.J., The effect of extremity vascular complications on the outcomes of cardiac support device recipients. J Vasc Surg 59 (2014), 1622–1627.